Fundraising Fox

Lifesproutbio

Delaware corporation · 3 known investors

lifesproutbio.com ↗

LifeSprout develops tissue-engineering products for aesthetic and regenerative medicine, designed to restore soft tissue losses caused by aging, cancer, and metabolic disease. The company creates bioengineered materials that mimic natural tissue structures for patients seeking restoration with minimal recovery time.

BiotechHealthtechMedical Devices

Founders & leadership

HM
Hai-Quan MaoExecutive Officer, Promoter
SR
Sashank ReddyExecutive Officer, Director, Promoter
GS
Gregory SieczkiewiczExecutive Officer, Director, Promoter

Investors · 3

Catalio Capital Management, LPNew York
Emerald Development ManagersNew York
Maryland TEDCOUpper Marlboro · $500K – $1.5M

Reported raises · per SEC filings

Form D private placements
▶$21.2MraisedJun 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sashank ReddyExecutive Officer, Director, Promoter
  • Adam GridleyDirector, Promoter
  • Amrit NagpalDirector
  • Xiaoming FangDirector
  • Gregory SieczkiewiczExecutive Officer, Promoter
  • Heather MurrenDirector
Offering amount
$26.2M
Amount sold
$21.2M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedMar 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hai-Quan MaoExecutive Officer, Promoter
  • Sashank ReddyExecutive Officer, Director, Promoter
  • Gregory SieczkiewiczExecutive Officer, Director, Promoter
Offering amount
$6.5M
Amount sold
$2.7M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.